Journal
CURRENT OPINION IN IMMUNOLOGY
Volume 21, Issue 2, Pages 200-208Publisher
CURRENT BIOLOGY LTD
DOI: 10.1016/j.coi.2009.02.004
Keywords
-
Categories
Funding
- Intramural NIH HHS [Z01 BC010763-02] Funding Source: Medline
Ask authors/readers for more resources
CD4(+) T cells are central to the function of the immune system but their role in tumor immunity remains underappreciated. It is becoming clear that there is an enormous diversity of CD4(+) T cell polarization patterns including Th1, Th2, Th17, and regulatory T cells (Tregs). These functionally divergent T cell subsets can have opposing effects - they can trigger tumor rejection or inhibit treatment after adoptive cell transfer. Some polarized CD4(+) cells have plasticity, and their phenotypes and functions can evolve in vivo. Recent advances in understanding of polarization and differentiation of lymphocytes, as well as some intriguing developments in the clinic, indicate that the use of CD4(+) T cell subsets in the immunotherapy of cancer has unrealized potential.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available